Intrinsiqq
DocCheck AG logo

DocCheck AG Dividend Analysis

AJ91.XETR

⊜ Compare
Dividend29

Does DocCheck (AJ91.XETR) pay a dividend?

High yield, verify sustainability

Yes. DocCheck (AJ91.XETR) pays a dividend: €1.00 per share over the last twelve months, a dividend yield of 9.52% at the latest close.

It has raised its dividend per share for 2 years in a row, growing at 0.0% a year over the last 5 years. The payout takes about 95.1% of earnings.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

0

Safety

40% of composite

Earnings Payout0
95.1%Stretched
FCF Coverage0
0.4xNot covered
10

Growth

35% of composite

Dividend Streak20
2YNo sustained streak
Growth Rate0
0.0%Declining
100

Income

25% of composite

Cash Yield (TTM)100
9.52%High, verify safety

Composite = Safety (0) × 0.40 + Growth (10) × 0.35 + Income (100) × 0.25 = 29

Dividend Safety

Earnings Payout

95.1%

FCF Payout

226.7%

FCF Coverage

0.4x

Dividend Growth

Per Share (TTM)

€1.00

Growth Streak

2 years

5Y CAGR

0.0%

Dividend history

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025€1.00+33.3%
2024€0.75+50.0%
2023€0.50-33.3%
2022€0.75-25.0%
2021€1.000.0%
2020€1.00+900.0%
2019€0.10-75.0%
2018€0.400.0%
2017€0.400.0%
2016€0.400.0%

Newest 10 of 12 fiscal years; the chart above has the full series. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend Income

Annual DPS (TTM)

€1.00

Annual Income / €10K

€952

Payment frequency, ex-dividend and payment dates are not available from company filings. Check your broker or the company's investor relations page for the schedule.

DocCheck (AJ91.XETR) dividend: yield, safety and growth

Frequently asked

Does DocCheck (AJ91.XETR) pay a dividend, and how much?+

Yes, DocCheck pays a regular dividend of about €1.00 per share per year (a yield of roughly 9.5%). That is a payout ratio of about 95.1% of earnings, so it is not currently covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.

Is DocCheck's dividend safe?+

DocCheck's dividend looks not currently covered by free cash flow, with free cash flow covering the payout about 0.4 times over. Intrinsiqq scores its dividend safety at 0 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.

Has DocCheck grown its dividend?+

DocCheck has raised its dividend for about 2 years in a row. Recent dividend growth has been roughly flat. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.

What is DocCheck's dividend payout ratio?+

DocCheck pays out about 95.1% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is not currently covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.

Peers

Health Information Services · Pick stocks to compare with AJ91.XETR

CompareIntrinsic value
7V0.XETRDarwin AG
€6.30-3.08%24
LIK.XETRLimes Schlosskliniken AG
€530.00+1.92%67
FYB.XETRFormycon AG
€18.68-1.68%10
V3V.XETRFamiCord AG
€2.68-3.94%39
M3V.XETRMeVis Medical Solutions AG
€19.90-0.50%48
GME.XETRGeratherm Medical AG
€2.13+0.00%47
AAQ1.XETRaap Implantate AG
€1.47+1.38%33
HPHA.XETRHeidelberg Pharma AG
€2.01-3.37%10

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AJ91.XETR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.